140 related articles for article (PubMed ID: 29806632)
1. Expression of glucocorticoid receptor shows negative correlation with human B-cell engraftment in PBMC-transplanted NOGhIL-4-Tg mice.
Seki T; Miyamoto A; Ohshima S; Ohno Y; Yasuda A; Tokuda Y; Ando K; Kametani Y
Biosci Trends; 2018 Jul; 12(3):247-256. PubMed ID: 29806632
[TBL] [Abstract][Full Text] [Related]
2. NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination.
Kametani Y; Katano I; Miyamoto A; Kikuchi Y; Ito R; Muguruma Y; Tsuda B; Habu S; Tokuda Y; Ando K; Ito M
PLoS One; 2017; 12(6):e0179239. PubMed ID: 28617827
[TBL] [Abstract][Full Text] [Related]
3. Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice.
Hanazawa A; Ito R; Katano I; Kawai K; Goto M; Suemizu H; Kawakami Y; Ito M; Takahashi T
Front Immunol; 2018; 9():152. PubMed ID: 29456539
[TBL] [Abstract][Full Text] [Related]
4. HER2-antigen-specific humoral immune response in breast cancer lymphocytes transplanted in hu-PBL hIL-4 NOG mice.
Ohno Y; Ohshima S; Miyamoto A; Kametani F; Ito R; Tsuda B; Kasama Y; Nakada S; Kashiwagi H; Seki T; Yasuda A; Ando K; Ito M; Tokuda Y; Kametani Y
Sci Rep; 2021 Jun; 11(1):12798. PubMed ID: 34140620
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
6. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
[TBL] [Abstract][Full Text] [Related]
8. Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses.
Yaguchi T; Kobayashi A; Inozume T; Morii K; Nagumo H; Nishio H; Iwata T; Ka Y; Katano I; Ito R; Ito M; Kawakami Y
Cell Mol Immunol; 2018 Nov; 15(11):953-962. PubMed ID: 29151581
[TBL] [Abstract][Full Text] [Related]
9. Improved engraftment of human peripheral blood mononuclear cells in NOG MHC double knockout mice generated using CRISPR/Cas9.
Ka Y; Katano I; Nishinaka E; Welcker J; Mochizuki M; Kawai K; Goto M; Tomiyama K; Ogura T; Yamamoto T; Ito M; Ito R; Takahashi R
Immunol Lett; 2021 Jan; 229():55-61. PubMed ID: 33253759
[TBL] [Abstract][Full Text] [Related]
10. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse.
Suzuki M; Takahashi T; Katano I; Ito R; Ito M; Harigae H; Ishii N; Sugamura K
Int Immunol; 2012 Apr; 24(4):243-52. PubMed ID: 22402880
[TBL] [Abstract][Full Text] [Related]
11. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
Katano I; Ito R; Eto T; Aiso S; Ito M
Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
[TBL] [Abstract][Full Text] [Related]
12. A Novel Xenogeneic Graft-Versus-Host Disease Model for Investigating the Pathological Role of Human CD4
Ito R; Katano I; Kawai K; Yagoto M; Takahashi T; Ka Y; Ogura T; Takahashi R; Ito M
Am J Transplant; 2017 May; 17(5):1216-1228. PubMed ID: 27862942
[TBL] [Abstract][Full Text] [Related]
13. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
[TBL] [Abstract][Full Text] [Related]
14. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
[TBL] [Abstract][Full Text] [Related]
15. Visualization of the human CD4⁺ T-cell response in humanized HLA-DR4-expressing NOD/Shi-scid/γc(null) (NOG) mice by retrogenic expression of the human TCR gene.
Takahashi T; Katano I; Ito R; Ito M
Biochem Biophys Res Commun; 2015 Jan; 456(1):219-24. PubMed ID: 25462565
[TBL] [Abstract][Full Text] [Related]
16. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.
Katano I; Takahashi T; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M
J Immunol; 2015 Apr; 194(7):3513-25. PubMed ID: 25712215
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model.
Ghosn S; Chamat S; Prieur E; Stephan A; Druilhe P; Bouharoun-Tayoun H
Front Immunol; 2018; 9():601. PubMed ID: 29628927
[TBL] [Abstract][Full Text] [Related]
18. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
[TBL] [Abstract][Full Text] [Related]
19. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
[TBL] [Abstract][Full Text] [Related]
20. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
